Austin

ProsperOps FinOps Platform Accepted Into AWS ISV Accelerate Program

Retrieved on: 
Tuesday, December 7, 2021
Cloud, Registered Disability Savings Plan, AWS, Risk, Cloud computing, GLOBE, Total cost of ownership, Amazon, Artificial Intelligence for IT Operations, ISV, TCO, Amazon Web Services, CEO, RIS, Disbursement Acceleration Program, DevOps, Financial management, Solution, Government, Friction

The ISV Accelerate Program streamlines the procurement process for startups, enterprises, and government agencies seeking solutions that run on or integrate with AWS.

Key Points: 
  • The ISV Accelerate Program streamlines the procurement process for startups, enterprises, and government agencies seeking solutions that run on or integrate with AWS.
  • The unique co-sell program connects AWS customers with partners, like ProsperOps, through a global network of AWS technologists.
  • As a result, AWS users with cost optimization needs can quickly and confidently secure ProsperOps through their AWS account team.
  • "The AWS ISV Accelerate Program focuses on helping AWS users get the most out of the cloud," noted Chris Cochran, CEO and co-founder of ProsperOps.

TFF Pharmaceuticals Hosting Science Day on December 13, 2021

Retrieved on: 
Monday, December 6, 2021

He has served as a Scientific Advisor to Gen9 (acquired by Gingko Bioworks), Chimera Bio and CytoKind, and consultant to Agios Pharmaceuticals and Constellation Pharmaceuticals.

Key Points: 
  • He has served as a Scientific Advisor to Gen9 (acquired by Gingko Bioworks), Chimera Bio and CytoKind, and consultant to Agios Pharmaceuticals and Constellation Pharmaceuticals.
  • TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform.
  • TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder.
  • To learn more about TFF Pharmaceuticals and its product candidates, visit the Companys website at https://tffpharma.com .

ProjectManager and PMI Host Free Virtual Panel on “Mastering the Hybrid World of Work” on Dec. 7th

Retrieved on: 
Thursday, December 2, 2021
Software as a service, NASA, Face, Marketing, Organization, University, VP, University of Washington Information School, Twitter, GLOBE, PPM, Hybrid, Avis, LinkedIn, CWM, PMI, Stephanie, Risk management

Shawn Dickerson, VP of Marketing for ProjectManager, is a passionate evangelist of the benefits of hybrid work management. With more than 20 years in high-tech marketing--and the last decade in the PPM and CWM spaces--Shawn brings a deep understanding of the challenges team members face in prioritizing, planning and delivering their best work.

Key Points: 
  • AUSTIN, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) -- ProjectManager and PMI are hosting a free virtual panel on Mastering the Hybrid World of Work, with insights on adapting project management processes to hybrid work environments to keep productivity and team engagement high regardless of location, work style or unique role.
  • This live panel webinar will address key questions, such as:
    What are the biggest challenges in project and work management today?
  • Stephanie Ray, VP of Product for ProjectManager, is responsible for guiding the roadmapof the companys hybrid work management solutions.
  • Shawn Dickerson, VP of Marketing for ProjectManager, is a passionate evangelist of the benefits of hybrid work management.

Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021

Retrieved on: 
Thursday, December 2, 2021
Patient, Autoimmune disease, Shattuck, Cancer, CD47, Lymphoma, TIGIT, GLOBE, Digital, NASDAQ, Event, Medical imaging

AUSTIN, TXandDURHAM, NC, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease with three ongoing Phase 1 clinical trials, today announced its presentation at the TIGIT Therapies Digital Summit 2021 being held virtuallyDecember 7 9, 2021.

Key Points: 
  • AUSTIN, TXandDURHAM, NC, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease with three ongoing Phase 1 clinical trials, today announced its presentation at the TIGIT Therapies Digital Summit 2021 being held virtuallyDecember 7 9, 2021.
  • The presentation will be available for download on the Events & Presentations section of the companys website and also will be available toregistered participants of the TIGIT Therapies Digital Summit 2021.
  • Shattuck Labs, Inc. (NASDAQ: STTK) is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.
  • Compounds derived from Shattucks proprietary Agonist Redirected Checkpoint, ARC, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic.

Review Health Insurance Options Before Open Enrollment Deadline

Retrieved on: 
Wednesday, December 1, 2021
Insurance, Review, Research, GLOBE, Affordable Care Act, Technology, Health insurance, Online shopping

AUSTIN, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- With the annual health insurance open enrollment deadline approaching, KindHealth , an all-in-one digital health insurance marketplace, advises people to review their insurance plans to avoid being automatically re-enrolled in a plan with new costs or reduced coverage.

Key Points: 
  • AUSTIN, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- With the annual health insurance open enrollment deadline approaching, KindHealth , an all-in-one digital health insurance marketplace, advises people to review their insurance plans to avoid being automatically re-enrolled in a plan with new costs or reduced coverage.
  • KindHealth is an insurance discovery platform that has already helped more than one million people buy health insurance coverage.
  • During the last open enrollment period, more than 12 million people enrolled in Affordable Care Act health insurance plans.
  • You may be able to get insurance coverage through a spouse, parent, state insurance marketplace, Medicaid, or short-term health insurance.

DroneSense Assisted Emergency Teams at Surfside Building Collapse

Retrieved on: 
Wednesday, December 1, 2021
Safety, Police, Emergency, Aircraft, City, Facebook, Inc., Twitter, GLOBE, Decision quality, Organization, Efficiency, Survivor, Risk management, Management

AUSTIN, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- DroneSense responded to a Florida emergency service's need for assistance following the Surfside building collapse and demonstrated its unmatched ability to provide collaborative unmanned aircraft software and logistical support in emergency and public safety efforts.

Key Points: 
  • AUSTIN, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- DroneSense responded to a Florida emergency service's need for assistance following the Surfside building collapse and demonstrated its unmatched ability to provide collaborative unmanned aircraft software and logistical support in emergency and public safety efforts.
  • An experienced DroneSense specialist was embedded with one of the emergency task force teams and assigned responsibilities for logistics and operations, contributing to safety, efficiency and situational awareness throughout the mission.
  • The DroneSense platform is purpose-built for public safety and is used by fire, police, and emergency medical professionals around the country.
  • DroneSense is a trademark of DroneSense, Inc., Facebook is a trademark of Facebook, Inc., and Twitter is a trademark of Twitter, Inc.

Atlas Technical Consultants to Present at the Credit Suisse 9th Annual Industrials Conference

Retrieved on: 
Wednesday, December 1, 2021
Government, Institute for Environmental Solutions, CEO, Credit, Conference, Climate, Quality management, Inspection, Transport, Health, Education, Investor, Nasdaq, Credit Suisse, GLOBE, CFO, Water, Infrastructure, Construction

AUSTIN, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (Atlas or the Company), a leading Infrastructure and Environmental solutions provider, announced today that Joe Boyer, CEO, and David Quinn, CFO, will present at the Credit Suisse 9th Annual Industrials Conference on Friday, December 3, 2021 at 8:50 a.m. Eastern Time.

Key Points: 
  • AUSTIN, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (Atlas or the Company), a leading Infrastructure and Environmental solutions provider, announced today that Joe Boyer, CEO, and David Quinn, CFO, will present at the Credit Suisse 9th Annual Industrials Conference on Friday, December 3, 2021 at 8:50 a.m. Eastern Time.
  • A live audio webcast will be available at the time of the event and may be accessed through the Investors section of the Companys website at https://www.oneatlas.com.
  • Headquartered in Austin, Texas, Atlas is a leading provider of Infrastructure and Environmental Solutions.
  • To learn more about Atlas innovations for transportation, commercial, water, government, education, and industrial markets, visit https://www.oneatlas.com.

Molecular Templates Provides Corporate Update and Outlines 2022 Milestones

Retrieved on: 
Tuesday, November 30, 2021
Patient, NSCLC, Pertuzumab, HER2, Trastuzumab, PD-L1, Technology, Company, Biology, Non-Hodgkin lymphoma, Multiple myeloma, MD, Cancer, Evercore, Tumor microenvironment, Șaeș, DLT, IND, ETB, NK, Myeloid-derived suppressor cell, Therapy, Breast cancer, SLAMF7, Melanoma, Infrared spectroscopy correlation table, Myocarditis, TIGIT, Cardiomyopathy, GLOBE, ETB (company), Antibody, CD38, Regulatory T cell, HLA-A2, PD-1, Immunotherapy, Doctor of Philosophy, CMV, MHC, Growth, NHL, CD8, Animal, Pharmaceutical industry, Vaccine, Gasoline

AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), provided a corporate update and outlined expected 2022 milestones.

Key Points: 
  • MTEM to Present at Evercore ISI 4th Annual HealthCONx on December 2nd, 2021
    AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, Molecular Templates, or MTEM or the Company), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), provided a corporate update and outlined expected 2022 milestones.
  • 2021 was a year of growth for MTEM as we advanced our multiple pipeline programs, said Eric Poma, Ph.D., Chief Executive and Chief Scientific Officer of Molecular Templates.
  • MT-6402 was designed to directly destroy PD-L1+ tumor cells and alter the immunosuppressive tumor microenvironment through direct cell-kill of PD-L1+ immune cells.
  • No approved checkpoint agent has shown an ability to alter immune subset composition or induce cytokine changes in a PD-L1-targeted fashion, said Roger Waltzman, MD, Chief Medical Officer of Molecular Templates.

Open Lending to Present at Upcoming Conferences

Retrieved on: 
Tuesday, November 30, 2021
Risk, GLOBE, Conference, Raymond James Financial, Solution, NASDAQ, Company, Bank

AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (Open Lending or the Company), a leading provider of lending enablement and risk analytics solutions to financial institutions, today announced that the Company will be participating at the following virtual investor conferences in December:

Key Points: 
  • AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (Open Lending or the Company), a leading provider of lending enablement and risk analytics solutions to financial institutions, today announced that the Company will be participating at the following virtual investor conferences in December:
    On Thursday, December 2, 2021, the Company will be participating at the DA Davidson FinTech & Payments Spotlight Conference.
  • On Monday, December 6, 2021, the Company will be hosting a fireside chat at the Raymond James Technology Investors Conference.
  • The Raymond James fireside chat can be accessed by visiting the Company's investor relations website at investors.openlending.com under the Events section.
  • Open Lending (NASDAQ: LPRO) provides loan analytics, risk-based pricing, risk modeling and default insurance to auto lenders throughout the United States.

Casoro Group Announces the Sale of 5 Multifamily Properties in Dallas/Fort Worth Market

Retrieved on: 
Tuesday, November 30, 2021
Sale, Workforce, Sun Belt, Savoy, Demographics of Dallas–Fort Worth, Better Homes and Gardens Real Estate, REIT, Investment, GLOBE, Work, Growth, Quality of life, Commercial property, Hotel

AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Casoro Group, a leading multifamily real estate investment firm based in Austin, Texas, announced today the sale of five multifamily properties in the Dallas-Fort Worth market, totaling 1,070 units.

Key Points: 
  • AUSTIN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Casoro Group, a leading multifamily real estate investment firm based in Austin, Texas, announced today the sale of five multifamily properties in the Dallas-Fort Worth market, totaling 1,070 units.
  • The sale represents Casoro Groups latest investment strategy to redirect capital to real estate properties focused on the knowledge worker market sector.
  • We would like to thank Civitas Capital Group for partnering with us on the investment in this multifamily portfolio and helping to make it a successful sale, Casoro Group CEO Yuen Yung said.
  • This sale comes at the perfect time for Casoro Group to realign with our knowledge worker real estate investment strategy in the Sunbelt region.